期刊
CANCER AND METASTASIS REVIEWS
卷 32, 期 1-2, 页码 109-122出版社
SPRINGER
DOI: 10.1007/s10555-012-9409-1
关键词
Prostate cancer; Genetically engineered mice; GEM models
类别
资金
- NIH [CA084294, CA141535, CA154293]
- T.J. Martell Foundation for Leukemia, Cancer and AIDS Research
- V-Foundation for Cancer Research
More than 15 years ago, the first generation of genetically engineered mouse (GEM) models of prostate cancer was introduced. These transgenic models utilized prostate-specific promoters to express SV40 oncogenes specifically in prostate epithelium. Since the description of these initial models, there have been a plethora of GEM models of prostate cancer representing various perturbations of oncogenes or tumor suppressors, either alone or in combination. This review describes these GEM models, focusing on their relevance for human prostate cancer and highlighting their strengths and limitations, as well as opportunities for the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据